Cargando…
Perspectives of Cell Sensitivity/Resistance Assay in Soft Tissue Sarcomas Chemotherapy
Treatment of highly malignant soft tissue sarcomas (STSs) requires multicomponent therapy including surgery, radiotherapy, and chemotherapy. Despite the advancements in targeted cancer therapies, cytostatic drug combinations remain the gold standard for STS chemotherapy. The lack of algorithms for p...
Autores principales: | Fetisov, Timur I., Khazanova, Sofya A., Shtompel, Polina A., Trapeznikova, Ekaterina S., Zinovieva, Victoria Y., Marshall, Valeria I., Lovenger, Anastasia A., Rogozhin, Dmitriy V., Anastasia, Tararykova A., Bokhyan, Beniamin Yu., Belitsky, Gennady A., Yakubovskaya, Marianna G., Kirsanov, Kirill I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10418362/ https://www.ncbi.nlm.nih.gov/pubmed/37569668 http://dx.doi.org/10.3390/ijms241512292 |
Ejemplares similares
-
Current Approaches for Personalized Therapy of Soft Tissue Sarcomas
por: Kirsanov, Kirill I., et al.
Publicado: (2020) -
Analysis of Multiple Drug Resistance Mechanism in Different Types of Soft Tissue Sarcomas: Assessment of the Expression of ABC-Transporters, MVP, YB-1, and Analysis of Their Correlation with Chemosensitivity of Cancer Cells
por: Moiseeva, Natalia I., et al.
Publicado: (2022) -
Soft Tissue Sarcoma Study: Association of Genetic Alterations in the Apoptosis Pathways with Chemoresistance to Doxorubicin
por: Kirilin, Evgeny M., et al.
Publicado: (2022) -
Prevention of therapy-related malignances in cancer survivors
por: Belitsky, Gennady A., et al.
Publicado: (2019) -
Insights into the Mechanism of Curaxin CBL0137 Epigenetic Activity: The Induction of DNA Demethylation and the Suppression of BET Family Proteins
por: Maksimova, Varvara, et al.
Publicado: (2023)